bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.12.12.520168

Measurement of expression from a limited number of genes is sufficient to predict flowering time in maize

Abstract

Changing patterns of weather and climate are limiting breeders ability to conduct trials in the same environments in which their released varieties will be grown 7-10 years later. Flowering time plays a crucial role in determining regional adaptation, and mismatch between flowering time and environment can substantially impair yield. Different approaches based on genetic markers or gene expression can be used to predict flowering time before conducting large scale field evaluation and phenotyping. The more accurate prediction of a trait using genetic markers could be hindered due to all the intermediate steps (i.e. transcription, translation, epigenetic modification, and epistasis among others) connecting the trait and their genetic basics. The use of some intermediate steps as predictors could improve the accuracy of the model. Here, we are using two public gene expression (RNA-Seq) data-sets from 14-day-old-maize-seedling roots and whole-seedling tissue at v1 stage (10 day after planting) for which flowering data (days to anthesis and days to silking expressed in growing degree days) and genetic markers were also available to test the predictability of flowering time. In total, 20 different combinations between phenotypic and gene expression data-sets were evaluated. To explore prediction accuracy a random forest model was trained with the expression values of 44,303 gene models hosted in the current B73 maize reference version 5 and then the feature importance was scored based on the decrease in root mean squared error. Later several random forest models with different subsets of the most important features (genes) were trained, and this process was repeated ten times. Results from these analyses show a curve in the prediction accuracy, with an increase in the prediction accuracy as the top most important genes were added. The maximum accuracy was attained when 500 genes for whole-seedling and 100 genes for root gene expression data were used in the analysis, and thereafter adding more genes lead to a decrease in the prediction accuracy. The highest prediction accuracy using the top-most important genes was higher than that of using randomly selected whole-genome 400,000 SNPs. Finally, we described the genes controlling flowering time by looking at the most important genes in the Random forest model with the expression data from all genes. We further found MADS-transcription factor 69 (Mads69) using whole-seedling gene expression and the MADS-transcription factor 67 (Mads67) using root gene expression data, both genes previously described with effect on flowering time. Here, we aim to demonstrate the potential of selecting and using the expression of most informative genes to predict a complex trait, also to demonstrate the robustness and limitations of this analysis by using phenotypic data-sets from different environments.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Torres-Rodriguez, J. V., Sun, G., Mural, R. V., Schnable, J. C.. 2022-12-14. Measurement of expression from a limited number of genes is sufficient to predict flowering time in maize. https://doi.org/10.1101/2022.12.12.520168

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Genomic correlates of metastatic competence and progression in human melanoma

Genomic events and their timing that grant a primary tumour the competence to disseminate remain poorly defined. We performed sequencing of 247 stage I/II primary cutaneous melanomas (CMs) and 60 matched metastases without intervening therapy from a prospectively followed registry cohort with a median followup of 92 months, integrating copy-number, mutational, protein and spatial-transcriptomic analyses. Relapse was not distinguished by oncogenic point mutations, which were largely shared between primaries and metastases, but by somatic copy-number alterations (SCNAs) and global chromosomal instability. We defined OncoCycle, a six-gene copy-number signature (amplification of CDK4, MCL1 and CD276; biallelic loss of CDKN2A, CDKN2B and TP53BP1) that predicted relapse independently of established clinicopathological features in melanoma, and a pan-cancer analysis. In matched pairs, metastatic progression was driven by continued copy-number evolution and reduction in intra-tumoural heterogeneity, rather than by acquired point mutations, and OncoCycle alterations from primary tumours were preserved in metastasis seeding clones. Clonal reconstruction revealed both monoclonal and polyclonal metastasis seeding, and spatial transcriptomics resolved copy-number-defined metastatic subclones occupying and programming distinct immune and stromal niches. Thus, metastatic competence was primed early by focal SCNAs on a background of chromosomal instability, elaborated by continued copy-number evolution during dissemination and spatio-temporal interactions with the tumour-microenvironment.

genomics↗

PfPHAST: Plasmodium falciparum Public Health Amplicon Sequencing Tool, a Streamlined Panel for Malaria Genomic Surveillance

Genomic tools can support malaria control policy through surveillance of Plasmodium falciparum populations, tracking antimalarial drug resistance, pfhrp2/3 deletions that compromise rapid diagnostic tests, and selection at the circumsporozoite protein (PfCSP) vaccine target, as well as through molecular correction of therapeutic efficacy studies (TES). Multiplex Amplicons for Drug, Diagnostic, Diversity, and Differentiation Haplotypes using Targeted Resequencing (MAD4HatTeR), a comprehensive amplicon sequencing panel covering up to 276 targets, supports these applications but is tailored to research rather than routine programmatic use. We developed P. falciparum Public Health Amplicon Sequencing Tool (PfPHAST), a 56-target derivative of MAD4HatTeR spanning drug resistance loci, pfhrp2/3 deletion, PfCSP genotyping, non-falciparum species identification, and 20 high-heterozygosity microhaplotype loci for TES classification. We compared PfPHAST and MAD4HatTeR using laboratory strain controls, including two-strain dilution series and a five-strain mixture, across parasite densities of 100 to 10,000 parasites/L. At matched per-target depth, PfPHAST achieved a higher quality-control pass rate than MAD4HatTeR (94.4% versus 90.0%) and distributed reads more evenly across targets. The panels showed comparable recall and precision for drug resistance codons and microhaplotypes, reaching near-complete recall above 40% within-sample allele frequency (WSAF) at all densities, with reduced sensitivity for minor alleles below 10% WSAF at low parasite density in both panels. Observed and expected WSAF correlated strongly for both panels, and both resolved a five-strain polyclonal mixture, including a 5% minor strain. By concentrating sequencing capacity on targets of greatest programmatic relevance, PfPHAST offers a scalable, lower-cost alternative to comprehensive research panels without sacrificing performance on shared targets, complementing MAD4HatTeR for routine molecular malaria surveillance.

genomics↗

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗